Viemed Healthcare, Inc.
VMD
$7.80
$0.405.41%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 19.62% | 17.41% | 26.91% | 27.90% | 35.28% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 19.62% | 17.41% | 26.91% | 27.90% | 35.28% |
| Cost of Revenue | 31.83% | 25.44% | 28.29% | 33.69% | 27.48% |
| Gross Profit | 12.54% | 12.46% | 25.99% | 24.15% | 40.25% |
| SG&A Expenses | 17.11% | 13.80% | 27.17% | 24.08% | 37.26% |
| Depreciation & Amortization | -20.97% | -16.95% | 26.51% | 72.92% | 80.08% |
| Other Operating Expenses | -438.46% | -573.17% | -16,750.00% | 67.90% | 138.24% |
| Total Operating Expenses | 22.65% | 18.09% | 26.30% | 27.98% | 32.71% |
| Operating Income | -4.68% | 10.94% | 34.70% | 26.41% | 60.08% |
| Income Before Tax | 24.21% | 29.72% | -26.59% | 5.10% | 41.63% |
| Income Tax Expenses | 17.64% | 20.76% | 5.49% | 3.39% | 39.53% |
| Earnings from Continuing Operations | 27.24% | 33.78% | -36.61% | 5.67% | 42.62% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 24.13% | 32.85% | -37.00% | 5.67% | 42.62% |
| EBIT | -4.68% | 10.94% | 34.70% | 26.41% | 60.08% |
| EBITDA | 1.59% | 8.87% | 26.24% | 30.39% | 46.37% |
| EPS Basic | 22.48% | 31.49% | -37.83% | 4.02% | 40.87% |
| Normalized Basic EPS | -8.09% | 5.37% | -15.20% | 15.29% | 49.83% |
| EPS Diluted | 35.79% | 42.57% | -37.00% | 0.50% | 24.65% |
| Normalized Diluted EPS | -9.32% | 5.51% | -13.75% | 15.06% | 48.67% |
| Average Basic Shares Outstanding | 1.39% | 1.13% | 1.30% | 1.47% | 1.25% |
| Average Diluted Shares Outstanding | 2.82% | 0.89% | -0.30% | 1.41% | 2.20% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
